
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Marinomed Biotech
Market Cap: €35.1m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€19.10
7D
0%
1Y
27.3%
Warimpex Finanz- und Beteiligungs
Market Cap: €25.5m
Operates as a real estate development and investment company in Austria, Germany, Hungary, Russia, and Poland.
WXF
€0.49
7D
8.2%
1Y
-21.4%